Patients with spondyloarthritis including psoriatic arthritis: Current needs, impact, and perspective.

[1]  M. Dougados,et al.  Instrument selection for the ASAS core outcome set for axial spondyloarthritis , 2022, Annals of the Rheumatic Diseases.

[2]  I. Peláez-Ballestas,et al.  Beyond Empowerment in Rheumatology Care , 2022, The Journal of Rheumatology.

[3]  H. Bootsma,et al.  Central sensitization has major impact on quality of life in patients with axial spondyloarthritis. , 2021, Seminars in arthritis and rheumatism.

[4]  V. Navarro-Compán,et al.  Test–retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis , 2021, RMD Open.

[5]  M. Dougados,et al.  The ASAS-OMERACT core domain set for axial spondyloarthritis. , 2021, Seminars in arthritis and rheumatism.

[6]  E. Loza,et al.  Current State, Control, Impact and Management of Rheumatoid Arthritis According to Patient: AR 2020 National Survey. , 2020, Reumatologia clinica.

[7]  Ji Hyoun Kim,et al.  Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta‐analysis , 2020, International journal of rheumatic diseases.

[8]  V. Strand,et al.  Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors , 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[9]  S. Ramiro,et al.  Work Disability in Axial Spondyloarthritis , 2020, Current Rheumatology Reports.

[10]  L. Carmona,et al.  The journey of the non-radiographic axial spondyloarthritis patient: the perspective of professionals and patients , 2020, Clinical Rheumatology.

[11]  L. Coates,et al.  Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis , 2020, Annals of the Rheumatic Diseases.

[12]  E. Soriano,et al.  Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America , 2020, Clinical Rheumatology.

[13]  Tsutomu Takeuchi,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update , 2020, Annals of the Rheumatic Diseases.

[14]  J. Craig,et al.  Patients’ Perspectives and Experience of Psoriasis and Psoriatic Arthritis: A Systematic Review and Thematic Synthesis of Qualitative Studies , 2020, Arthritis care & research.

[15]  M. Garrido-Cumbrera,et al.  Atlas of axial spondyloarthritis in Spain 2017: Study design and population. , 2019, Reumatologia clinica.

[16]  L. Gossec,et al.  The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective—an Analysis of 2846 Patients Across 13 Countries , 2019, Current Rheumatology Reports.

[17]  A. Gottlieb,et al.  Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta‐analysis of observational and clinical studies , 2019, Journal of the American Academy of Dermatology.

[18]  S. Siebert,et al.  Services for spondyloarthritis: a survey of patients and rheumatologists , 2018, Rheumatology.

[19]  M. Redondo,et al.  Expert recommendations on the psychological needs of patients with rheumatoid arthritis , 2018, Rheumatology International.

[20]  E. de Miguel,et al.  Development of a checklist for patients with axial spondyloarthritis and psoriatic arthritis in daily practice: ONLY TOOLS project. , 2018, Reumatologia clinica.

[21]  M. Dougados,et al.  2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis , 2017, Annals of the rheumatic diseases.

[22]  A. Jamshidi,et al.  Diagnostic Delay in Ankylosing Spondylitis: Related Factors and Prognostic Outcomes. , 2016, Archives of rheumatology.

[23]  L. Carmona,et al.  Motivations and objections to implement a spondyloarthritis integrated care pathway. A qualitative study with primary care physicians. , 2013, Reumatologia clinica.

[24]  C. Hernández García,et al.  Characteristics of patients with spondyloarthritis followed in rheumatology units in Spain. emAR II study. , 2012, Reumatologia clinica.

[25]  L. Carmona,et al.  Variability in resource consumption in patients with spondyloarthritis in Spain. Preliminary descriptive data from the emAR II study. , 2012, Reumatologia clinica.

[26]  L. Carmona,et al.  A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: the Esperanza Program , 2011, Annals of the rheumatic diseases.

[27]  L. Gossec.  Patient-Reported Outcomes in Rheumatoid Arthritis: Why are They Important and How Should They Be Assessed? , 2010 .

[28]  C. Fernández Carballido.  [Diagnosing early spondyloarthritis in Spain: the ESPeranza program]. , 2010, Reumatologia clinica.